Elisa Toropainen

University of Eastern Finland — Finland

Medicine · Health Sciences

27h-index2.7kcitations70works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(21), Retinal Development and Disorders(16), Ocular Surface and Contact Lens(14), Glaucoma and retinal disorders(12), Advanced Drug Delivery Systems(12)

Publications70 total

Progressive rod bipolar cell loss, ubiquitin accumulation, and subretinal drusenoid deposits in Cln3Δex7/8 mice: New insights into juvenile neuronal ceroid lipofuscinosis pathogenesis
Experimental Eye Research·2025Open Access
Rapid elimination of suprachoroidally injected small molecule drugs into the systemic blood circulation
European Journal of Pharmaceutical Sciences·2025Open Access
Intravitreal Sustained Release of Dexamethasone from a Self-Healing Injectable Hydrogel: An In Vivo Safety and Release Study
Molecular Pharmaceutics·2025Open Access
Drug release and pharmacokinetics of intravitreal liposomal injections: a case study with cyclic guanosine monophosphate derivative
European Journal of Pharmaceutical Sciences·2025· 1 citedOpen Access
New insights on liposomal formulations based upon tear film lipids: A combined study of safety and ocular surface pharmacokinetics
European Journal of Pharmaceutical Sciences·2025· 1 citedOpen Access
Melanin-Binding-Based Discovery of Topically Instilled Carbonic Anhydrase Inhibitors for Targeted Delivery and Prolonged Action in the Eye
Molecular Pharmaceutics·2025· 4 citedOpen Access
Assessment of silica as an intravitreal drug delivery vehicle in a preclinical in vivo tolerability study
Acta Ophthalmologica·2025· 1 cited
Ultrastructural analysis of retinal pigment epithelial cells in 5XFAD mouse model
Acta Ophthalmologica·2025· 1 cited
5XFAD/LC3 mice as a model to investigate autophagy mechanism in the eye
Acta Ophthalmologica·2025· 1 cited
Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits
European Journal of Pharmaceutics and Biopharmaceutics·2024· 5 citedOpen Access
Novel melanin‐binding carbonic anhydrase <scp>II</scp> inhibitor for long‐acting topical glaucoma treatment
Acta Ophthalmologica·2024
A 15 month follow‐up study characterizing the progression of retinal pathology and visual loss in <scp>CLN3</scp> ex7/8 mice
Acta Ophthalmologica·2024
Increased secretory autophagy in retinal pigment epithelial cells of the 5xFAD mice
Acta Ophthalmologica·2024
Comprehensive Ocular and Systemic Pharmacokinetics of Dexamethasone after Subconjunctival and Intravenous Injections in Rabbits
SSRN Electronic Journal·2023Open Access
Secretory autophagy is increased in <scp>5xFAD</scp> mice
Acta Ophthalmologica·2022
Imaging, quantitation and kinetic modelling of intravitreal nanomaterials
International Journal of Pharmaceutics·2022· 26 citedOpen Access
SCD1-Fatty Acid Desaturase Inhibitor MF-438 Alleviates Latent Inflammation Induced by Preservative-Free Prostaglandin Analog Eye Drops
SHILAP Revista de lepidopterología·2022· 5 citedOpen Access
Understanding dexamethasone kinetics in the rabbit tear fluid: Drug release and clearance from solution, suspension and hydrogel formulations
European Journal of Pharmaceutics and Biopharmaceutics·2022· 21 citedOpen Access
Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison
International Journal of Pharmaceutics·2022· 19 citedOpen Access
5xFAD mouse model develops visual dysfunction together with protein aggregation
Acta Ophthalmologica·2022
page 1 of 4Next →

Frequent Co-authors

Arto Urtti(39), Marika Ruponen(23), Kati‐Sisko Vellonen(17), Veli‐Pekka Ranta(15), Eva M. del Amo(13), Kai Kaarniranta(11), Amir Sadeghi(10), Seppo Auriola(9), Annika Valtari(9), Jooseppi Puranen(8), Mika Reinisalo(6), Emma M. Heikkinen(5), Eva Ramsay(5), Ali Koskela(5), Adrian Smędowski(5), Anu Talvitie(5), Shirin Tavakoli(5), Tatu Lajunen(4), Astrid Subrizi(4), Jussi J. Paterno(4)